Pain & Central Nervous System Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain & Central Nervous System Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Multiple Sclerosis
Autologous stem cell transplantation can be beneficial
March 31st, 2003
by Michael Greer, senior medical writer - Multiple sclerosis (MS) sufferers may benefit from hematopoietic stem cell autografts, researchers in Spain say. Enric Carreras and colleagues at the University of Barcelona Hospital Clinic conducted a "phase II trial to evaluate the feasibility and toxicity of CD34+ selected" autologous stem cell transplantation (CD34+/ASCT). Treatment with CD34+/ASCT slowed or reversed MS progression with limited toxicity, Carreras and coauthors found. The researchers performed CD34+/ASCT on 15 patients with advanced secondary progressive (SP) or relapsing-remitting (RR) MS. All of the transplanted...
Source: Pain & Central Nervous System Week (2003-03-31)
|
